Supply of Medicine and Medical / Surgical equipments : Rabies Vaccine (Human use) 0.5mL/1mL-\nInactivated\nRabies Vaccine (Human use)(0.5ml/1ml).\nEach dose 0.1ml to contain at least 7 IU/ml of rabies\nAntigen as an inactivated freeze-dried powder form.\nEach vial should be either 0.5mL or 1mL.\nThe Vaccine should be suitable for human use,\nproduced in cell culture.(Eg. Primary chickembryo cell\nculture Rabies Vaccine, Vero cell Rabies Vaccine).\nThe vaccine should comply with the Rabies Vaccine\nas the Pharmacopoeial requirement of Vaccine and\nbiological products.\nNote:\n1.Cold Chain monitors or WHO recommended other\ncold chain monitoring device should be included for\neach cartoon and the cold chain should be\nmaintained according to the manufacturer’s\ninstructions during storage, transport & delivery of\nvaccine.\n2.The following documents should be submitted pre-\nshipment for each lot of vaccine dispatched.\n(a).Invoice (b).Certificate of origin (c).Certificate of\nanalysis. (d).Lot release certificate from National\nControl Laboratory (NCL) from country of\norigin.(e).Summary lot protocols of production\nprocedure & quality control testing. (f) Packing list.\n(g) Copy of product information leaflet (PIL).These\ndocuments should be submitted pre-shipment to the\nNational Control Laboratory for Vaccines (NCL-MRI)\nSri Lanka. etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Rabies Vaccine (Human use) 0.5mL/1mL-\nInactivated\nRabies Vaccine (Human use)(0.5ml/1ml).\nEach dose 0.1ml to contain at least 7 IU/ml of rabies\nAntigen as an inactivated freeze-dried powder form.\nEach vial should be either 0.5mL or 1mL.\nThe Vaccine should be suitable for human use,\nproduced in cell culture.(Eg. Primary chickembryo cell\nculture Rabies Vaccine, Vero cell Rabies Vaccine).\nThe vaccine should comply with the Rabies Vaccine\nas the Pharmacopoeial requirement of Vaccine and\nbiological products.\nNote:\n1.Cold Chain monitors or WHO recommended other\ncold chain monitoring device should be included for\neach cartoon and the cold chain should be\nmaintained according to the manufacturer’s\ninstructions during storage, transport & delivery of\nvaccine.\n2.The following documents should be submitted pre-\nshipment for each lot of vaccine dispatched.\n(a).Invoice (b).Certificate of origin (c).Certificate of\nanalysis. (d).Lot release certificate from National\nControl Laboratory (NCL) from country of\norigin.(e).Summary lot protocols of production\nprocedure & quality control testing. (f) Packing list.\n(g) Copy of product information leaflet (PIL).These\ndocuments should be submitted pre-shipment to the\nNational Control Laboratory for Vaccines (NCL-MRI)\nSri Lanka. etc . in Healthcare Equipment and Services. The tender was released on Jun 13, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Rabies Vaccine (Human use) 0.5mL/1mL-\nInactivated\nRabies Vaccine (Human use)(0.5ml/1ml).\nEach dose 0.1ml to contain at least 7 IU/ml of rabies\nAntigen as an inactivated freeze-dried powder form.\nEach vial should be either 0.5mL or 1mL.\nThe Vaccine should be suitable for human use,\nproduced in cell culture.(Eg. Primary chickembryo cell\nculture Rabies Vaccine, Vero cell Rabies Vaccine).\nThe vaccine should comply with the Rabies Vaccine\nas the Pharmacopoeial requirement of Vaccine and\nbiological products.\nNote:\n1.Cold Chain monitors or WHO recommended other\ncold chain monitoring device should be included for\neach cartoon and the cold chain should be\nmaintained according to the manufacturer’s\ninstructions during storage, transport & delivery of\nvaccine.\n2.The following documents should be submitted pre-\nshipment for each lot of vaccine dispatched.\n(a).Invoice (b).Certificate of origin (c).Certificate of\nanalysis. (d).Lot release certificate from National\nControl Laboratory (NCL) from country of\norigin.(e).Summary lot protocols of production\nprocedure & quality control testing. (f) Packing list.\n(g) Copy of product information leaflet (PIL).These\ndocuments should be submitted pre-shipment to the\nNational Control Laboratory for Vaccines (NCL-MRI)\nSri Lanka. etc .

Deadline - Jun 30, 2025

GT reference number - 110901639

Product classification - Post-mortem and mortuary equipment and supplies